Baxiva at World Vaccine Congress Europe 2026

Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website

Baxiva takes part in 1 session at World Vaccine Congress Europe 2026 in Amsterdam, and exhibits at Booth SU31. Baxiva brings sugar-protein conjugate vaccines aimed at bacterial infections, starting with urinary tract and invasive infections caused by E. coli.

OrganizationWorld Vaccine Congress Europe 2026 Attendance
baxiva.com
Biotech
Start-up developing glycoconjugate vaccines against bacterial infections, led by a program to prevent urinary tract and invasive E. coli infections.
Booth
Exhibiting at Booth SU31
Talk
Tue Oct 20
13:15
Start-up Pitch 8: Baxiva AG
Startup Pitches

Explore the full World Vaccine Congress Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full World Vaccine Congress Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Baxiva

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the World Vaccine Congress or its organizers. Submit a correction